Using the multiplex PCR tubes of the BIOMED-2 Concerted Action, TCRB gene rearrangements were detected in 35% of childhood (n ¼ 161) and adult (n ¼ 172) precursor-B-ALL patients (Vb-(Db)-Jb in 25%; Db-Jb in 15%). The presence of TCRB rearrangements showed a significant relation with age (highest frequency of 46% between 5 and 10 years of age) and the presence of TEL-AML1 transcripts, and was associated with relatively high frequencies of IGK-Kde, TCRG, and Vd2-Ja rearrangements. In 62 out of 65 patients with Southern blotdetected Vb-(Db)-Jb and/or Db-Jb rearrangements, at least one TCRB gene rearrangement was detected by PCR. Based on combined Southern blot and PCR analysis, oligoclonal TCRB gene rearrangements were observed in only 12% of patients. Analysis of paired diagnosis and relapse samples (n ¼ 26) showed that 20 out of 24 (83%) Vb-(Db)-Jb rearrangements and eight out of 14 (57%) Db-Jb rearrangements remained stable. Using real-time quantitative PCR, a quantitative range p10
Introduction
Several studies have shown that detection of minimal residual disease (MRD) in childhood and adult ALL is clinically relevant. [1] [2] [3] [4] [5] [6] [7] [8] Detection of MRD can be used to evaluate the early treatment response, and thereby allows the identification of low-and high-risk patients who may profit from therapy reduction or therapy intensification, respectively. [1] [2] [3] [4] 9 Furthermore, detection of MRD just prior to stem cell transplantation has been shown to be an important prognostic factor. 5, 6, 10, 11 Therefore, MRD is currently being incorporated into stratification of treatment protocols. [12] [13] [14] Immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements can be found in over 95% of ALL patients 9, 15 and may serve as sensitive MRD-PCR targets for real-time quantitative PCR (RQ-PCR) analysis. [16] [17] [18] [19] [20] [21] [22] [23] Currently, rearrangements of the Ig heavy chain (IGH), Ig kappa light chain (IGK), TCR gamma (TCRG) and TCR delta (TCRD) genes are most frequently used as MRD-PCR targets in MRD studies of childhood and adult precursor-B-ALL. 9 However, the number of available MRD-PCR targets varies with age, with less MRD-PCR targets available in the precursor-B-ALL patients younger than 3 or over 10 years of age. 15 Furthermore, MRD-PCR targets in these patients are often oligoclonal and thus have a high chance of being lost during follow-up. 9, 15, 24 The relatively high number of potential MRD-PCR targets in precursor-B-ALL patients between 3 and 10 years of age is partly due to the high frequency of TCRG gene rearrangements in these patients. TCRG gene rearrangements are, however, poor MRD-PCR targets for RQ-PCR analysis, as sensitivities of at least 10 À4 are only reached in less than half of the patients. 21 Inclusion of new MRD-PCR targets is therefore convenient for clinical MRD studies that need sensitivities of at least 10 À4 , that is, for recognition of low-risk patients. 3, 14, 25 Cross-lineage TCRB gene rearrangements can be found in many B-cell malignancies. 26 In precursor-B-ALL, TCRB gene rearrangements can be observed in approximately 30-35% of patients, [26] [27] [28] [29] [30] [31] [32] and appear to be dependent on the immunophenotype (virtual absence of TCRB gene rearrangements in pro-B-ALL) 30, [32] [33] [34] [35] and age (low frequency in infants). 34, 36 TCRB gene rearrangements in precursor-B-ALL almost exclusively involve the Jb2 locus, 26, 29, 32, 37 which may be related with the methylation status of the TCRB gene. 38, 39 Furthermore, similar to the hierarchical order during T-cell development, TCRB gene rearrangements in precursor-B-ALL appear to be preceded by TCRD and subsequent TCRG gene rearrangements. 27, 28, 32, 40 So far, TCRB gene rearrangements have not been used as MRD-PCR targets in precursor-B-ALL because of the many primers that are needed to detect TCRB gene rearrangements. The TCRB gene consists of at least 65 rearrangeable Vb gene segments (27 Vb families), two Db segments (Db1 and Db2), two clusters of Jb gene segments (Jb1.1-Jb1.6 and Jb2.1-Jb2.7), and two Cb gene segments. 41, 42 This complexity has hampered PCR analysis of TCRB gene rearrangements, but recently the BIOMED-2 Concerted Action BMH4-CT98-3936 'PCR-based clonality studies for early diagnosis of lymphoproliferative disorders' succeeded in the design of a multiplex PCR approach for easy and rapid detection of TCRB gene rearrangements. 43 The purpose of this study was to evaluate the applicability of TCRB gene rearrangements as sensitive and stable MRD-PCR targets for quantitative MRD detection in precursor-B-ALL. To that end, we evaluated the frequency, characteristics of the junctional region, and stability of TCRB gene rearrangements in a large series of childhood and adult precursor-B-ALL. Finally, we evaluated TCRB gene rearrangements by RQ-PCR analysis using recently designed TCRB primer-probe sets in combination with allele-specific oligonucleotides (ASO) as forward primers. 44 Our data indicate that TCRB gene rearrangements can easily be detected by the BIOMED-2 primer set in about one-third of precursor-B-ALL patients and that particularly complete Vb-DbJb rearrangements are sensitive and stable MRD-PCR targets.
Materials and methods

Patients
Bone marrow (BM) and/or peripheral blood (PB) samples were obtained from 161 consecutive childhood precursor-B-ALL patients at initial diagnosis. Based on routine immunophenotyping, 2, 67, and 31% were classified as pro-B-ALL, common-ALL, and pre-B-ALL, respectively. In all, 65 additional childhood precursor-B-ALL patients were selected, based on the availability of TCRB Southern blot data and sufficient amounts of DNA. The Southern blot data of these patients were published previously 32 and all 65 patients contained at least one Southern blot-detectable TCRB gene rearrangement. From 22 out of these 65 patients, BM and/or PB samples were also obtained at relapse. Four additional childhood precursor-B-ALL patients were studied both at diagnosis and at relapse as well.
BM and/or PB samples were collected from 254 adult precursor-B-ALL patients. In total, 172 patients were consecutively enrolled without any selection; based on routine immunophenotyping, 13, 65, and 22% were classified as pro-B-ALL, common-ALL, and pre-B-ALL, respectively. Eighty-two adult precursor-B-ALL patients, consecutively enrolled but excluding pro-B-ALL and BCR-ABL-positive cases, were included in our study as well.
From three adult and three childhood precursor-B-ALL patients, 56 BM samples, acquired during follow-up within the German multicenter ALL Study GMALL 06/99 or the Dutch Childhood Leukemia Study Group (DCLSG) ALL8 or ALL9 studies, were analyzed as well. From all samples, mononuclear cells (MNC) were separated and DNA was isolated as described previously. 45 All patient samples were obtained according to the informed consent guidelines of the local or national medical ethics committees.
PCR heteroduplex analysis of TCRB gene rearrangements
The BIOMED-2 multiplex TCRB PCR heteroduplex assay (with 23 consensus Vb, 2 Db and 13 Jb primers in three multiplex tubes; InVivoScribe Technologies, USA; www.invivoscribe. com) was used for identification of monoclonal TCRB rearrangements. 43 Vb primer codes were derived from their corresponding Vb segments using the nomenclature that was proposed by Arden et al.
42
Relapse samples were at first analyzed with those primer combinations, which showed clonal PCR products at diagnosis. When the clonal PCR product was also found at relapse, its identity was subsequently compared with the PCR product found at diagnosis by means of mixed heteroduplex analysis. 24, 46 When clonal PCR products found at diagnosis were undetectable at relapse, also the relapse sample was analyzed with the BIOMED-2 multiplex TCRB PCR heteroduplex assay.
IGH, IGK-Kde, TCRG, and TCRD gene rearrangements were detected as described previously. 47, 48 Vd2-Ja rearrangements were detected using a recently developed multiplex strategy. 49 
Sequence analysis
Fluorescent sequencing was performed using the Big Dye-terminator cycle sequencing kit and an ABI 377 automated sequencer (Applied Biosystems, Foster City, CA, USA) as described previously. 20, 21, 44 Vb and Jb segments were identified using the ImMunoGeneTics database (IMGT; http:// imgt.cines.fr, initiator and coordinator: Marie-Paule Lefranc, Montpellier, France), 50 based on the complete DNA sequence of the human TCRB locus using the nomenclature proposed by Rowen et al.
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Southern blot analysis of TCRB gene rearrangements Southern blot was performed for 65 childhood precursor-B-ALL patients at diagnosis, using EcoRI-and HindIII-digested DNA and TCRBD1U, TCRBD1, TCRBJ1, TCRBD2U, TCRBD2, TCRBJ2, and TCRBC probes (DAKO Cytomation, Carpinteria, CA, USA) as described previously. 51 Based on the combined information of these different probes, incomplete TCRB gene rearrangements (Db-Jb) can be identified with a high degree of reliability, because Db-Jb rearrangements are defined via upstream Db probes (TCRBD1U and TCRBD2U) as well as downstream Jb probes (TCRBJ1 and TCRBJ2). 51 Complete TCRB gene rearrangements (Vb-(Db)-Jb) are assumed to be present if rearranged bands are observed using the TCRBJ1 or TCRBJ2 probe and if no rearranged bands are detected with the TCRBD1U, TCRBD1, TCRBD2U, and/or TCRBD2 probes. Consequently, identification of complete TCRB rearrangements (Vb-(Db)-Jb) with Jb probes is somewhat less reliable than identification of Db-Jb rearrangements with both Db and Jb probes. Therefore, it cannot be excluded that some Southern blot-assumed Vb-Jb rearrangements represent atypical rearrangements.
Real-time quantitative PCR
Totally, 13 germline Jb primers and Jb TaqMan probes were designed 44 and RQ-PCR was performed on an ABI PRISM 7700 or ABI PRISM 7000 thermal cycler (Applied Biosystems) as described previously. 20, 21, 44 Data were collected and analyzed using the Sequence Detection Software (Applied Biosystems). Data interpretation was performed as described previously, 23, 44 generally according to the guidelines recently developed by 26 European MRD laboratories participating in the European Study Group on MRD detection in ALL (coordinators: JJM van Dongen and VHJ van der Velden). To correct for the quantity and quality (amplifiability) of DNA, we used RQ-PCR analysis of the albumin gene. 16 
Statistical analysis
Statistical analysis using the w 2 -test or Fisher's exact test was performed for comparison of patient and disease characteristics (immunophenotype, Ig/TCR gene rearrangements, fusion gene transcripts). To compare the prevalence of TCRB gene rearrangements between different age groups of childhood precursor-B-ALL patients, the w 2 -test was used (with calculation of exact Pvalues in case of low prevalences). P-values less than or equal to 0.05 were considered statistically significant.
Results
Frequency of TCRB gene rearrangements in precursor-B-ALL patients
The BIOMED-2 primer set 43 was used to evaluate the frequency of TCRB gene rearrangements in a random series of childhood (n ¼ 161) and adult precursor-B-ALL (n ¼ 172) patients. As shown in Table 1 , the overall frequency of TCRB gene rearrangements was 33 and 38% in childhood and adult precursor-B-ALL patients, respectively. Complete TCRB gene rearrangements (Vb-(Db)-Jb) were more frequent (22 and 28% of childhood and adult precursor-B-ALL patients, respectively) than incomplete TCRB gene rearrangements (Db-Jb; 14 and 16% of childhood and adult precursor-B-ALL patients, respectively). In approximately 65% of patients with TCRB gene rearrangements, the recombination concerned only one allele (ie only one complete or one incomplete TCRB rearrangement was detected; see Table 1 ).
In children, the frequency of TCRB gene rearrangements was not significantly different between common-ALL (36%) and pre-B-ALL (31%); the number of pro-B-ALL cases in our series (2%) was too low to draw reliable conclusions. In adults, the frequency of TCRB gene rearrangements in pro-B-ALL, common-ALL, and pre-B-ALL was 19, 44, and 28%, respectively; this difference was not statistically significant.
Although the overall frequency of TCRB gene rearrangements was comparable between children and adults, a significant relation with age was observed: TCRB gene rearrangements were observed in none of the children o1.5 years, in 29% of children between 1.5 and 5 years, 46% of children between 5 and 10 years, and 36% of children between 10 and 16 years of age (Po0.05 by w 2 -test). Within the group of adult patients no significant age relationship was found.
TCRB gene rearrangements and presence of fusion gene transcripts
In 74 childhood precursor-B-ALL patients, the presence of MLL-AF4, BCR-ABL, and TEL-AML1 fusion gene transcripts was analyzed. 52 TCRB gene rearrangements were observed in 24% of patients without any of these fusion gene transcripts. In TEL-AML1-positive patients (27% of childhood precursor-B-ALL patients), TCRB gene rearrangements were observed in 80% of cases. TCRB gene rearrangements were present in one out of three BCR-ABL-positive patients; MLL-AF4-positive patients were not detected in this series of childhood precursor-B-ALL. In adult precursor-B-ALL, 165 patients were analyzed for the presence of t(9;22) and/or BCR-ABL transcripts and 31 (19%) were found to be positive. There was no significant difference in the frequency of TCRB gene rearrangements between patients with or without BCR-ABL transcripts (45 and 38%, respectively). In contrast, in none of the 18 adult patients with t(4;11) and/or MLL-AF4 fusion gene transcripts, TCRB gene rearrangements were detected.
Detection of TCRB gene rearrangements in precursor-B-ALL: comparison between Southern blot and PCR analysis
To evaluate whether the BIOMED-2 primers, originally developed for application in mature T-cell malignancies, can detect all complete (Vb-(Db)-Jb) and incomplete (Db-Jb) TCRB gene rearrangements in precursor-B-ALL, we selected 65 childhood precursor-B-ALL, which were previously shown to have rearranged TCRB genes by Southern blot analysis. 32 In total, 99 alleles (including 11 alleles from five oligoclonal patients; see below) were found to be rearranged by Southern blotting: 55 Vb-(Db)-Jb2, 27 Db-Jb2, 12 unidentified-Jb2, 2 Db1-Db2, and 5 Vb-Db2 gene rearrangements. By PCR analysis, a total of 77 rearrangements was detected: 46 Vb-(Db)-Jb2 and 31 Db-Jb2 gene rearrangements. All incomplete TCRB gene rearrangements detected by Southern blot were also detected by PCR analysis. In contrast, only 38 out of 55 (69%) Southern blotassumed complete TCRB gene rearrangements were found using PCR analysis. Seven out of 12 Southern blot-detected unidentified-Jb2 gene rearrangements were identified by PCR: five Vb-(Db)-Jb2, one Db1-Db2-Jb2, and one Db1-Jb2 gene rearrangement. Three Vb-(Db)-Jb2 and two Db-Jb2 gene rearrangements were only detected by PCR analysis, suggesting a subclonal origin (see below). Despite the relatively low concordance between Southern blot and PCR analysis of complete TCRB gene rearrangements, in only three (5%) out of the 65 patients with Southern blot-detectable TCRB gene rearrangements, no TCRB gene rearrangement could be detected by PCR analysis.
By Southern blot analysis, five (8%) out of 65 patients appeared to have TCRB gene rearrangements in subclones, indicating oligoclonality. In an additional three patients, PCR analysis detected TCRB gene rearrangements not detected by Southern blot, suggesting subclonal origin. Consequently, based on combined Southern blot and PCR analysis, eight patients (12%) showed oligoclonal TCRB gene rearrangements. Because we only included patients who were proven to have rearranged TCRB gene rearrangements by Southern blot analysis (ie PCR analysis of remaining patients was not performed), it may be that Table 1 Frequencies of TCRB gene rearrangements in precursor-B-ALL patients
Because of the complex structure of the TCRB locus with two Db-Jb regions per allele, it is possible to have two 'separate' rearrangements per allele, that is, four 'separate' TCRB rearrangements per cell.
the actual percentage of TCRB oligoclonal patients is slightly higher.
TCRB gene rearrangement patterns in precursor-B-ALL
To analyze their characteristics in more detail, TCRB gene rearrangements present in childhood (n ¼ 108) and adult (n ¼ 69) precursor-B-ALL were sequenced. As shown in Figure 1a , the vast majority of complete TCRB gene rearrangements involved the most downstream V gene segments, although other, more upstream-located V gene segments were used as well at low frequency.
In childhood precursor-B-ALL, Db segments could be identified in 39 out of 69 complete Vb-(Db)-Jb rearrangements (57%): 12 Db1 and 27 Db2. In adult precursor-B-ALL, 34 out of 47 complete TCRB gene rearrangements (72%) contained an identifiable Db segment: 17 Db1 and 17 Db2 (Table 2 ). In concordance with previously published data, 26, 29, 32, 37 virtually all complete TCRB gene rearrangements involved Jb2 gene segments (Figure 1b) . In both childhood and adult precursor-B-ALL, Jb2.3, Jb2.5 and Jb2.7 were used most frequently.
Incomplete TCRB gene rearrangements in childhood precursor-B-ALL showed a slight predominance of the Db1 gene segment (59%, Table 2 ), whereas the Db2 gene segment slightly predominated in incomplete TCRB gene rearrangements present in adult precursor-B-ALL (55%). Jb gene segment usage in incomplete TCRB gene rearrangements was comparable to that in complete TCRB gene rearrangements with predominance of Jb2.3, Jb2.5 and Jb2.7 (Figure 1c) .
Junctional region characteristics of TCRB gene rearrangements in childhood and adult precursor-B-ALL are shown in Table 2 . In 16% of children and 3% of adults no inserted N nucleotides were found in the Db-Jb junction.
Complementarity of TCRB gene rearrangements with other Ig/TCR targets
To determine whether the presence of TCRB gene rearrangements was associated with the presence of other Ig/TCR gene rearrangements, PCR analysis of IGH, IGK-Kde, TCRD, TCRG, and Vd2-Ja gene rearrangements was performed in a total of 157 childhood precursor-B-ALL patients. As shown in Table 3 , the presence of complete TCRB gene rearrangements (Vb-Jb) was associated with significantly higher frequencies of IGK (Vk-Kde and intron RSS-Kde), TCRG, and TCRD/A (Vd2-Ja) rearrangements. Patients with only incomplete TCRB gene rearrangements showed an Ig/TCR gene rearrangement pattern in between patients without TCRB gene rearrangement and patients with complete TCRB gene rearrangements.
Patients without TCRB gene rearrangements showed an average of 3.8 rearrangements in one of the other Ig/TCR loci (IGH, IGK-Kde, TCRD, TCRG). Patients with incomplete TCRB gene rearrangements only showed an average of 4.6 other rearrangements, whereas an average of 5.2 was observed in Figure 1 Vb and Jb gene segment usage in childhood and adult precursor-B-ALL. TCRB gene rearrangements were sequenced and aligned using IMGT software (IMGT.cines.fr) and the TCRB sequence obtained by Rowen et al (accession numbers: U66059; U66060; U66061). 41 patients with complete TCRB gene rearrangements (Table 3) . Of those patients with TCRB gene rearrangements, only a single patient (with one incomplete TCRB gene rearrangement) had only one other detected Ig/TCR gene rearrangement. If TCRG gene rearrangements (which in precursor-B-ALL often do not reach good sensitivities (at least 10 À4 ) in RQ-PCR analysis), 21 were excluded, five patients with TCRB gene rearrangements had only one other detected Ig/TCR gene rearrangement.
Stability of TCRB gene rearrangements between diagnosis and relapse in precursor-B-ALL
The stability of TCRB gene rearrangements was analyzed by comparative PCR heteroduplex analysis of paired diagnosis and relapse samples from 26 childhood precursor-B-ALL patients, selected out of 79 relapsed precursor-B-ALL patients based on the presence of at least one TCRB gene rearrangement at diagnosis. At diagnosis, 24 complete TCRB gene rearrangements and 14 incomplete TCRB gene rearrangements were detected. At relapse, 20 out of 24 (83%) complete TCRB gene rearrangements and eight out of 14 (57%) incomplete TCRB gene rearrangements remained stable (Table 4) . Monoclonal TCRB gene rearrangements were more stable than oligoclonal TCRB gene rearrangements (Table 4 ). In five out of 26 patients (19%), all TCRB gene rearrangements were lost at relapse, whereas in one patient (DCOG 5559) two TCRB gene rearrangements were lost but one remained stable. In the remaining 20 patients (77%) all TCRB gene rearrangements remained stable between diagnosis and relapse. The relapse samples of five patients with at least one TCRB gene rearrangement lost at relapse were further analyzed by PCR and sequencing to follow the patterns of clonal evolution (Figure 2 ). In patient DCOG 5559, one stable Vb20.1-Db1-Jb2.3 rearrangement was found at relapse, whereas a Vb12.5-Jb2.7 and Db2-Jb2.7 rearrangement were lost, suggesting loss of a subclone. In patient DCOG 2717, secondary (ongoing) rearrangements of the Db2-Jb2.7 rearrangement detected at diagnosis resulted in a Db1-Db2-Jb2.7 rearrangement at relapse. In addition, a new and unrelated Vb14-Jb2.7 rearrangement was detected at relapse. In patient DCOG 3559 and DCOG 5199 completely new and unrelated TCRB gene rearrangements were detected at relapse with no evidence for common Db-Jb stems or secondary rearrangements. However, Table 2 Characteristics of junctional regions of TCRB gene in childhood and adult precursor-B-ALL TCRB rearrangements in precursor-B-ALL VHJ van der Velden et al RQ-PCR analysis of the diagnosis sample using the TCRB gene rearrangement detected at relapse showed that in both patients the relapse clone was already present at diagnosis, although at low levels (around 1%). In patient DCOG 5199, the Db1-Jb2.7 rearrangement found at diagnosis could be due to ongoing rearrangements of the Db2-Jb2. 
Real-time quantitative PCR analysis of TCRB gene rearrangements
We recently designed TaqMan primer-probe sets for detection of TCRB gene rearrangements by RQ-PCR analysis in patients with T-ALL. 44 To determine the applicability in precursor-B-ALL patients, we tested 42 complete TCRB gene rearrangements and 16 incomplete TCRB gene rearrangements using this primerprobe set in combination with ASO forward primers. As shown in Table 5 , RQ-PCR analysis of complete TCRB gene rearrangements (Vb-Jb) resulted in a quantitative range of at least 10 À4 in 28 out of 42 (67%) cases. In 36 cases (86%), a sensitivity of at least 10 À4 was obtained and a quantitative range of 10 À3 was obtained in all cases. Incomplete TCRB gene rearrangements (Db-Jb) were slightly less suitable for sensitive RQ-PCR analysis: a quantitative range of at least 10 À4 was obtained in nine out of 16 (56%) cases. Nevertheless, in 14 cases (88%) a sensitivity of at least 10 À4 was obtained and a quantitative range of 10 À3 was obtained in 15 cases (94%). Nonspecific amplification of related TCRB gene rearrangements present in normal MNC was the main reason for limited sensitivity and was observed in 62% of cases (Table 5 ). In 36% of cases, the annealing temperature had to be increased to obtain sufficient discrimination between specific and nonspecific amplification (ie DCtZ3).
To evaluate the suitability of TCRB gene rearrangements as MRD-PCR targets in precursor-B-ALL, we determined MRD levels in a total of 56 follow-up samples from six patients using RQ-PCR analysis of TCRB gene rearrangements and compared the results with previously obtained data using other MRD-PCR targets in these follow-up samples. As shown in Figure 3 , MRD analysis using TCRB gene rearrangements gave comparable results as MRD analysis using other MRD-PCR targets. Only if MRD levels were outside the quantitative range (o10 À4 ; ie outside the range of the RQ-PCR analysis in which reproducible data can be obtained), some discrepancies were observed.
Discussion
The development of multiplex primer sets for detection of TCRB gene rearrangements by the BIOMED-2 Concerted Action 43 allows rapid and easy detection and identification of 
Figure 2
Clonal evolution phenomena in patients with at least one TCRB gene rearrangement lost at relapse. Schematic representation of the clonal evolution phenomena observed in five childhood precursor-B-ALL patients in whom at least one TCRB gene rearrangement was lost at relapse. See text for details.
cross-lineage TCRB gene rearrangements in patients with precursor-B-ALL. In this study, we show that TCRB gene rearrangements can be found in about one-third of precursor-B-ALL patients and that they can serve as stable and generally sensitive targets for RQ-PCR-based detection of MRD.
Previous studies identified TCRB gene rearrangements in 30-35% of precursor-B-ALL patients. [27] [28] [29] [30] [31] [32] In concordance with these data, we could detect TCRB gene rearrangements by PCR analysis in 33% (children) or 38% (adults) of precursor-B-ALL patients. However, only 69% of Southern blot assumed complete TCRB gene rearrangements were detected using the applied BIOMED-2 TCRB primers set, which was primarily designed for clonality analysis in mature T-cell malignancies and therefore mainly focussed on functional Vb gene segments. This is in contrast to T-ALL, in which a concordance between Southern blot and PCR data of over 90% was observed. 53 Probably, a part of the Southern blot-detected complete TCRB gene rearrangements in precursor-B-ALL involve one of the 17-25 nonfunctional but rearrangeable Vb gene segments (either pseudogenes or open-reading frames; eg Vb12.1, Vb12.2, Vb16, Vb22, and Vb26) partially not recognized by the BIOMED-2 primer set. Alternatively, the Southern blotassumed complete rearrangements in fact may be atypical rearrangements, which cannot be detected using the BIOMED-2 primer set. If this indeed is the case, then such atypical rearrangements are apparently more frequent in precursor-B-ALL than in T-ALL. Finally, as a result of the multiplexing of the primers in the BIOMED-2 tubes, it is possible that a second rearrangement is missed due to preferential amplification of a TCRB gene rearrangement detected within the same tube. However, detailed analysis of patients with Southern blotassumed biallelic complete TCRB gene rearrangements showed that this did not occur in our study (data not shown). Despite the relatively low concordance between PCR-detected complete TCRB gene rearrangements and Southern blot-assumed complete TCRB gene rearrangements, in 95% of precursor-B-ALL patients with Southern blot-detectable TCRB gene rearrangements at least one TCRB gene rearrangement was detected by PCR analysis.
TCRB gene rearrangements showed a significant relation with age, with a virtual absence in infants 34, 36 and the highest prevalence (46%) in the children between 5 and 10 years of age. Furthermore, patients with complete TCRB gene rearrangements (Vb-Jb) showed a higher frequency of IGK, TCRG and Vd2-Ja rearrangements, that is, a more mature Ig/TCR gene rearrangement pattern. These data are in agreement with our recently published data showing that the prevalence of IGK, TCRG, and TCRD gene rearrangements is highest in children between 3 and TCRB rearrangements in precursor-B-ALL VHJ van der Velden et al 10 years of age. 15 The relatively high frequency of TCRB gene rearrangements in this subset of children may be related to the latency period of the leukemic cell 15 and/or the high frequency of TEL-AML1-positive patients within this age category. 54 Indeed, TEL-AML1-positive patients showed a very high frequency of TCRB gene rearrangements (80%). Furthermore, the high frequency of TCRG and TCRD gene rearrangements in the patients with TCRB gene rearrangements indicate that, similarly to the hierarchical order during T-cell development, TCRB gene rearrangements in precursor-B-ALL patients are preceded by TCRD and TCRG gene rearrangements. 27, 28, 30, 32, 33, 40, 55, 56 TCRB gene rearrangements in precursor-B-ALL patients (both children and adults) showed a restricted gene segment usage: particularly the most downstream Vb gene segments were used and virtually all rearrangements involved the Jb2 locus. This is in clear contrast to T-ALL, in which Vb gene segment usage is much more scattered and in which also the Jb1 locus is involved. 44 Apparently, in precursor-B-ALL the TCRB locus, like the TCRD locus, is only partially accessible for the recombinase enzyme complex. Nevertheless, complete TCRB gene rearrangements can be formed and this may even result in the transcription of TCRB mRNA. 28 In our study, sequence data from 40 complete TCRB gene rearrangements showed that in 13 rearrangements (33%) the sequence was in-frame. Using RT-PCR analysis, 57 TCRB mRNA could be detected in all four patients analyzed (data not shown). However, to our knowledge, TCRb protein has so far however not been detected in precursor-B-ALL patients.
Comparison of TCRB gene rearrangements between diagnosis and relapse showed a good stability for complete TCRB gene rearrangements (83%), whereas the stability of incomplete TCRB gene rearrangements was lower (57%). TCRB gene rearrangements were particularly stable if they concerned monoclonal rearrangements, a phenomenon that we reported previously for IGH, IGK, and TCRD gene rearrangements. 24, 46, 49, 58 Because oligoclonality for TCRB gene rearrangements (about 15%) is lower than for IGH (about 40%) and TCRD (about 24%) gene rearrangements, 15 the overall stability of TCRB gene rearrangements (74%) seems to be slightly higher than the overall stability of IGH (64%) and TCRD gene rearrangements (63%). 24 Nevertheless, in six patients at least one TCRB gene rearrangement was lost at relapse. Several clonal evolution phenomena were observed, including ongoing or secondary rearrangements, selective outgrowth of a subclone, and outgrowth of a preleukemic clone (Figure 2) . Comparable phenomena were recently demonstrated for other Ig/TCR gene rearrangements 24, 46, 59, 60 and altogether these data further support the concept that at least two Ig/TCR rearrangements should be used as MRD-PCR target in ALL. 9 Because TCRB gene rearrangements can serve as MRD-PCR targets in ALL patients, we recently designed primer-probe sets for RQ-PCR analysis of these rearrangements and tested the sets in a series of T-ALL patients. 44 We now show that these new TCRB primer-probe sets can also be used for sensitive MRD detection in precursor-B-ALL patients. Particularly complete TCRB gene rearrangements showed a good quantitative range (r10 À4 in about two-third of cases), while incomplete TCRB gene rearrangements resulted in a good quantitative range in 56% of cases. However, in the vast majority (86% of TCRB gene rearrangements) a sensitivity of at least 10 À4 was reached. The slightly lower sensitivities obtained with incomplete TCRB gene rearrangements can be explained by the more limited combinatorial and junctional diversity of Db-Jb rearrangements, thereby resulting in increased amplification of TCRB gene rearrangements present in normal cells. This may particularly affect MRD monitoring during induction therapy, when mature T-cells (containing TCRB gene rearrangements) are relatively frequent in BM samples. 61 Although TCRB gene rearrangements are virtually always accompanied by other rearrangements, they have the advantage of: 1, low oligoclonality (IGK-KdeoTCRBoTCRGoTCRDoIGH); 2, good target stability (IGK-Kde4TCRBETCR-G4IGH4TCRD); and 3, good sensitivity in RQ-PCR analysis (IGHETCRDEIGK-Kde4TCRB4TCRG). 15, 20, 21, 24, 32 It is obvious that TCRB gene rearrangements represent a favorable MRD-PCR target, which facilitates the selection of two gene rearrangements with a relatively high chance of good stability and sensitivity. Therefore, we recommend including TCRB gene rearrangements in the initial target identification PCR. Selection of Ig/TCR gene rearrangements can subsequently be based on clonality status (preferably selection of monoclonal targets), estimated stability (selection of targets with high chance of being stable), and the chance of achieving a good sensitivity in the patient-specific RQ-PCR (a.o. dependent on gene segments, characteristics of the junctional region, and background of comparable rearrangements in normal cells).
In conclusion, TCRB gene rearrangements occur in about one-third of precursor-B-ALL patients and show a specific gene segment usage (involving particularly the most downstream Vb gene segments and Jb2 segments). TCRB gene rearrangements can be used as stable (at least one TCRB gene rearrangement stable in 81% of patients) and sensitive targets (sensitivity p10 À4 in almost 85% of cases) for RQ-PCR-based detection of MRD in patients with precursor-B-ALL.
